First-Night Polysomnography in Suspected Narcolepsy with a Normal Night
A 24-year-old graduate student has 2 years of excessive daytime sleepiness with irresistible sleep attacks, cataplexy triggered by laughter, and hypnagogic hallucinations. He takes no medications and has no other medical history. Overnight polysomnography shows total sleep time 7.1 hours, sleep efficiency 88%, no significant sleep-disordered breathing (AHI 1.2), normal limb movements, and a sleep-onset REM period (SOREMP) at 8 minutes after sleep onset. The next-day MSLT shows mean sleep latency 4.5 minutes with two SOREMPs (one at 3 minutes, one at 12 minutes). The patient asks whether he needs a lumbar puncture for hypocretin and whether the MSLT is 'definitive'.
1. How do you interpret the PSG and MSLT findings, and what is the diagnostic significance of the SOREMP on the overnight study?
Read the worked answer
Interpretation: The overnight PSG demonstrates a SOREMP (REM within 15 minutes of sleep onset), which is abnormal and, together with the MSLT findings (mean sleep latency <=8 minutes and >=2 SOREMPs), meets the classic MSLT criteria for narcolepsy. The presence of cataplexy plus hypnagogic hallucinations makes narcolepsy type 1 the leading diagnosis.
Judgment points: (1) A SOREMP on the overnight PSG can substitute for one of the two required MSLT SOREMPs in current criteria, so the overnight SOREMP plus one MSLT SOREMP can satisfy the SOREMP requirement - but this depends on the specific criteria version; the key is that the combination is strongly supportive. (2) The MSLT must be preceded by adequate sleep (>=6 hours) and the patient must be off REM-suppressing medications; here that is satisfied. (3) The MSLT is not 'definitive' in isolation - it is a supportive test with false positives (sleep deprivation, circadian misalignment, depression) and false negatives. Clinical features (cataplexy) carry major weight.
Answer to the patient: The MSLT is strongly supportive but not a stand-alone gold standard; the combination of cataplexy, PSG SOREMP, and MSLT result is highly consistent with narcolepsy type 1.
2. Should a CSF hypocretin measurement be obtained? What would it add, and what are the caveats?
Read the worked answer
CSF hypocretin-1 (orexin-A) is low/undetectable in most narcolepsy type 1 patients and can be useful when the diagnosis is uncertain, when the MSLT is equivocal or confounded, or when cataplexy is atypical. It is not routinely required when clinical features plus PSG/MSLT are already diagnostic. Caveats: it requires a lumbar puncture, results can be affected by assay and handling, and low levels are not universal (some type 1 patients have normal levels, and levels can be normal in type 2). The judgment point: order it to resolve diagnostic uncertainty, not to 'confirm' an already clear diagnosis, and interpret it alongside clinical and electrophysiologic data.